Learning from the HISTORY OF WINE
The Emerald Triangle has been the biggest producer and exporter of Cannabis in the U.S. since the late 60’s,
In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma
Neuroblastoma (nbl) is one of the most common solid cancers in children. Prognosis in advanced nbl is still poor despite aggressive multimodality therapy. Furthermore, survivors experience severe long-term multi-organ sequelae. Hence, the identification of new therapeutic strategies is of utmost importance. Cannabinoids and their derivatives have been used for years in folk medicine and later in the field of palliative care. Recently, they were found to show pharmacologic activity in cancer, including cytostatic, apoptotic, and antiangiogenic effects.
Cannabis: The Lost Legacy of Landrace Strains by Fred Delisio
Instead of trying to “reinvent-the-wheel” and breeding new strains that may or may not have greater amounts of this cannabinoid or that, or this terpene profile, we have the opportunity to test strains
Scotland beats Ben & Jerry’s to CBD ice cream
When I first thought of the idea I didn’t think CBD oil had a lot of public acceptance.
Integrating cannabis into clinical cancer care
Cannabis species have been used as medicine for thousands of years; only since the 1940s has the plant not been widely available for medical use. However, an increasing number of jurisdictions are making it possible for patients to obtain the botanical for medicinal use. For the cancer patient, cannabis has a number of potential benefits, especially in the management of symptoms. Cannabis is useful in combatting anorexia, chemotherapy-induced nausea and vomiting, pain, insomnia, and depression.
Isle Of Man Government announces results on public consultations
The response to this has been overwhelming. In fact, it’s amongst the highest number of responses we have ever had since the Government set up the Consultation Hub more than two years ago.
The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD.
Dr. Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and Medical Director of PHYTECS, a biotechnology company researching and developing innovative approaches targeting the human endocannabinoid system. His research interests have included correlations of historical uses of Cannabis with modern pharmacological mechanisms, phytopharmaceutical treatment of migraine and chronic pain, and phytocannabinoid/terpenoid/serotonergic/vanilloid interactions.
Is Cannabidiol a Promising Substance for New Drug Development? A Review of its Potential Therapeutic Applications
The pharmacological importance of cannabidiol (CBD) has been in study for several years. CBD is the major nonpsychoactive constituent of plant Cannabis sativa and its administration is associated with reduced side effects. Currently, CBD is undergoing a lot of research which suggests that it has no addictive effects, good safety profile and has exhibited powerful therapeutic potential in several vital areas.
Research offers insight into how vets use pot donated by SCVA
This study confirms what we’ve been seeing on the ground for years now
Dutch Cities reject cannabis regulation plan, continue with ‘backdoor problem’
Under existing Netherlands law, cannabis can be legally sold, but not cultivated.